Lusaris Therapeutics, Inc. — Form D

Lusaris Therapeutics, Inc. of Morrisville, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-06. The offering totals $60.2M, of which $60.2M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (9)

NameRoleLocation
DANIEL GRAUDirectorWALTHAM, MA
Andrew LevinDirectorBOSTON, MA
Edward MonaghanDirectorMorrisville, NC
Neil BuckleyExecutive OfficerBoston, MA
Ramin Farzaneh-FarExecutive OfficerSan Diego, CA
Andrew LevinExecutive OfficerBOSTON, MA
Edward MonaghanExecutive OfficerMorrisville, NC
CATHERINE RIESENExecutive OfficerWALTHAM, MA
Edward MonaghanPromoterMorrisville, NC

More